{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:28:55Z","timestamp":1793330935469,"version":"4.5.0"},"reference-count":94,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Scabies is a prevalent dermatological condition with significant public health implications. The recent rise in drug-resistant scabies presents new challenges for effective disease management and control. Methods: A comprehensive literature review was conducted using PubMed, Cochrane Library, and Web of Science. Studies published from 2000 to August 2024 were considered, focusing on those reporting drug-resistant scabies and advancements in treatment approaches. Results: Clinical studies, in vitro investigations, and case reports show significant resistance of human scabies to permethrin. Main resistance mechanisms involve genetic mutations in the mites\u2019 voltage-gated sodium channels (VGSCs) and enhanced activity or expression of the detoxifying enzyme glutathione S-transferase (GST). Resistance to ivermectin and benzyle benzoate, although suggested by some authors, seems less obvious. The clinical evidence of widespread ivermectin resistance in human scabies infestations is lacking, despite indications of increased tolerance in laboratory settings and anecdotal reports of resistance in patients with crusted scabies. Benzyl benzoate resistance in scabies mites remains unconfirmed. Conclusions: Permethrin-resistant scabies is an escalating threat requiring new management strategies and updated guidelines. Infection control measures, alternative treatments, and ongoing research into new therapeutics are crucial to mitigate the impact of drug-resistant scabies.<\/jats:p>","DOI":"10.3390\/jcm13185511","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T09:49:19Z","timestamp":1726652959000},"page":"5511","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Escalating Threat of Drug-Resistant Human Scabies: Current Insights and Future Directions"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6658-7965","authenticated-orcid":false,"given":"Thierry","family":"Simonart","sequence":"first","affiliation":[{"name":"Department of Dermatology, Delta Hospital, CHIREC, Universit\u00e9 Libre de Bruxelles, 1160 Bruxelles, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6007-0666","authenticated-orcid":false,"given":"Xu\u00e2n-Lan","family":"Lam Hoai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St Pierre\u2014Brugmann\u2014HUDERF University Hospitals, Universit\u00e9 Libre de Bruxelles, 1000 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jaad.2019.05.109","article-title":"Ectoparasites: Scabies","volume":"82","author":"Thomas","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/ijd.15318","article-title":"Prevalence of scratching during examination among patients with scabies and among patients with other pruritic dermatoses","volume":"60","author":"Hoai","year":"2020","journal-title":"Int. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMcp052784","article-title":"Clinical practices","volume":"354","author":"Chosidow","year":"2006","journal-title":"Scabies. N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/jdv.19167","article-title":"Prevalence of scabies worldwide\u2014An updated systematic literature review in 2022","volume":"37","author":"Schneider","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(19)31136-5","article-title":"The public health control of scabies: Priorities for research and action","volume":"394","author":"Engelman","year":"2019","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e2024112","DOI":"10.5826\/dpc.1402a112","article-title":"Dermatology Quality of Life and Depression, Anxiety, and Stress Scale-42 in Scabies Patients","volume":"14","author":"Altay","year":"2024","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"190020","DOI":"10.2807\/1560-7917.ES.2019.24.23.190020","article-title":"Increase of scabies infestations, Norway, 2006 to 2018","volume":"24","author":"Amato","year":"2019","journal-title":"Eurosurveillance"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S1473-3099(15)00132-2","article-title":"Prevalence of scabies and impetigo worldwide: A systematic review","volume":"15","author":"Romani","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","first-page":"15","article-title":"Increase of scabies in Germany and development of resistant mites? Evidence and consequences","volume":"17","author":"Aebischer","year":"2018","journal-title":"JDDG J. der Dtsch. Dermatol. Ges."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tmaid.2019.02.002","article-title":"The increase in Croatia\u2019s scabies incidence: How did refugees and traveling contribute?","volume":"29","year":"2019","journal-title":"Travel. Med. Infect. Dis."},{"key":"ref_11","unstructured":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 1545\u20131602."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jdin.2021.08.003","article-title":"Epidemiologic evolution of common cutaneous infestations and arthropod bites: A Google Trends analysis","volume":"5","author":"Simonart","year":"2021","journal-title":"JAAD Int."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"van Deursen, B., Hooiveld, M., Marks, S., Snijdewind, I., van den Kerkhof, H., Wintermans, B., Bom, B., Schimmer, B., and Fanoy, E. (2022). Increasing incidence of reported scabies infestations in the Netherlands, 2011-2021. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0268865"},{"key":"ref_14","first-page":"E346","article-title":"Prescriptions for scabies are rapidly increasing in Spain: An ecological study with national prescription data, 2008\u20132021","volume":"37","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Dela\u0161 A\u017edaji\u0107, M., Be\u0161li\u0107, I., Ga\u0161i\u0107, A., Ferara, N., Pedi\u0107, L., and Lugovi\u0107-Mihi\u0107, L. (2022). Increased Scabies Incidence at the Beginning of the 21st Century: What Do Reports from Europe and the World Show?. Life, 12.","DOI":"10.3390\/life12101598"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Uzun, S., Durdu, M., Y\u00fcrekli, A., M\u00fclayim, M.K., Akyol, M., Velipa\u015fao\u011flu, S., Harman, M., Taylan-\u00d6zkan, A., \u015eavk, E., and Demir-Dora, D. (2024). Clinical practice guidelines for the diagnosis and treatment of scabies. Int. J. Dermatol.","DOI":"10.1111\/ijd.17327"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"T475","DOI":"10.1016\/j.ad.2024.03.016","article-title":"Spanish Academy of Dermatology and Venereology (AEDV) expert recommendations for the management of sexual transmitted parasitosis. Scabies, and pediculosis pubis","volume":"115","year":"2024","journal-title":"Actas Dermosifiliogr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jdv.14351","article-title":"European guideline for the management of scabies","volume":"31","author":"Salavastru","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_19","unstructured":"Sashidharan, P. (2024, July 24). 2016 UK National Guideline on the Management of Scabies. Available online: https:\/\/www.bashh.org\/_userfiles\/pages\/files\/resources\/scabies_2016.pdf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"E557","DOI":"10.1111\/jdv.18026","article-title":"Topical ivermectin: An off-label alternative to treat neonatal Scabies in the era of permethrin resistance","volume":"36","author":"Bassi","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1111\/jdv.18181","article-title":"European scabies challenge: What about permethrin-resistant mites?","volume":"36","author":"Mayer","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/bjd\/ljad308","article-title":"Failure of scabies treatment: A systematic review and meta-analysis","volume":"190","author":"Mbuagbaw","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"102545","DOI":"10.1016\/j.tmaid.2023.102545","article-title":"A resistant parasitic flare-up amid children in Italy: Comment on \u201cDiagnosis and management of pediatric scabies: Results from a survey on 317 Italian dermatologists\u201d","volume":"52","author":"Herzum","year":"2023","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1017\/S0950268816001746","article-title":"The management of scabies outbreaks in residential care facilities for the elderly in England: A review of current health protection guidelines","volume":"144","author":"White","year":"2016","journal-title":"Epidemiol. Infect."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.2020-12-3","article-title":"Paediatrics: How to manage scabies","volume":"10","author":"Thompson","year":"2021","journal-title":"Drugs Context"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/ajd.13654","article-title":"A narrative review of the roles of topical permethrin and oral ivermectin in the management of infantile scabies","volume":"62","author":"Lobo","year":"2021","journal-title":"Australas. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Betlloch-Mas, I., Boluda-Verd\u00fa, E., Jara-Rico, N., S\u00e1nchez-Garc\u00eda, V., Gracia, L.B.-D., and Chiner-Vives, E. (2024). Scabies in Infants: Series of 51 Cases. Children, 11.","DOI":"10.3390\/children11040443"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0035-9203(00)90454-1","article-title":"Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis","volume":"94","author":"Walton","year":"2000","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1086\/421776","article-title":"First Documentation of In Vivo and In Vitro Ivermectin Resistance in Sarcoptes scabiei","volume":"39","author":"Currie","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4269\/ajtmh.2006.74.649","article-title":"PCR-based assay to survey for knockdown resistance to pyrethroid acaricides in human scabies mites (Sarcoptes scabiei var hominis)","volume":"74","author":"Pasay","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1080\/09546634.2020.1774489","article-title":"Loss of efficacy of topical 5% permethrin for treating scabies: An Austrian single-center study","volume":"33","author":"Meyersburg","year":"2020","journal-title":"J. Dermatol. Treat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"E889","DOI":"10.1111\/jdv.17538","article-title":"Scabies is becoming less sensitive to permethrin therapy","volume":"35","author":"Balestri","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/09564624241242167","article-title":"Scratching beneath the surface: An evaluation of the management of scabies 2017\u20132023","volume":"35","author":"Broster","year":"2024","journal-title":"Int. J. STD AIDS"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00105-020-04608-0","article-title":"Increase of scabies and therapy resistance among German military personnel An 8-year follow-up study in the Department of Dermatology of the Armed Forces Hospital Berlin, Germany (2012-2019)","volume":"71","author":"Elsner","year":"2020","journal-title":"Der Hautarzt"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.medcli.2023.11.012","article-title":"Permethrin-resistant scabies","volume":"162","author":"Giavedoni","year":"2024","journal-title":"Med. Clin."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2242539","DOI":"10.1080\/09546634.2023.2242539","article-title":"Treatment of permethrin-resistant scabies with pyrethrins\/piperonyl butoxide foam","volume":"34","author":"Veraldi","year":"2023","journal-title":"J. Dermatol. Treat."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e2024029","DOI":"10.5826\/dpc.1401a29","article-title":"Topical Ivermectin for Permethrin-Resistant Scabies: A Useful Application","volume":"14","author":"Gnesotto","year":"2024","journal-title":"Dermatol. Pr. Concept."},{"key":"ref_38","first-page":"163","article-title":"Topical treatment failure in scabies: A survey in resistant patients","volume":"158","author":"Trave","year":"2023","journal-title":"Ital. J. Dermatol. Venerol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00105-021-04783-8","article-title":"Scabies-clinical resistance to permethrin therapy: Case reports and a critical discussion of current treatment recommendations","volume":"72","author":"Mang","year":"2021","journal-title":"Der Hautarzt"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Khalil, S., Abbas, O., Kibbi, A.G., and Kurban, M. (2017). Scabies in the age of increasing drug resistance. PLOS Neglected Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005920"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jdv.17713","article-title":"Risk factors for scabies treatment resistance: A retrospective cohort study","volume":"36","author":"Lee","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/archdermatol.2009.125","article-title":"Longitudinal Evidence of Increasing In Vitro Tolerance of Scabies Mites to Ivermectin in Scabies-Endemic Communities","volume":"145","author":"Mounsey","year":"2009","journal-title":"Arch. Dermatol."},{"key":"ref_43","first-page":"e15260","article-title":"Is there a really resistance to scabies treatment with permethrin? In vitro killing activity of permethrin on Sarcoptes scabiei from patients with resistant scabies","volume":"35","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_44","first-page":"19052","article-title":"A persistent problem with scabies in and outside a nursing home in Amsterdam: Indications for resistance to lindane and ivermectin","volume":"13","author":"Baayen","year":"2008","journal-title":"Eurosurveillance"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e15495","DOI":"10.1111\/dth.15495","article-title":"Use of oral ivermectin in permethrin-resistant scabies: A pilot study","volume":"35","author":"Balestri","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/jdv.18573","article-title":"Comparison of topical benzyl benzoate vs. oral ivermectin in treating scabies: A randomized study","volume":"37","author":"Meyersburg","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e01678","DOI":"10.1016\/j.idcr.2023.e01678","article-title":"Pruritic papules and nodules as sign of persistent scabies infestation despite treatment according to current guidelines evidence for treatment resistance to ivermectin, benzylbenzoat and permethrin proven by videomicroscopy","volume":"31","author":"Lehmann","year":"2023","journal-title":"IDCases"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2915.2008.00716.x","article-title":"High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites","volume":"22","author":"Pasay","year":"2008","journal-title":"Med. Vet. Entomol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1756-3305-3-43","article-title":"Increased transcription of Glutathione S-transferases in acaricide exposed scabies mites","volume":"3","author":"Mounsey","year":"2010","journal-title":"Parasites Vectors"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/bjd.18517","article-title":"In vitro ovicidal activity of current and under-development scabicides: Which treatments kill scabies eggs?","volume":"182","author":"Bernigaud","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"40129","DOI":"10.57187\/smw.2023.40129","article-title":"National survey in Switzerland calls for improved diagnosis and treatment in children with scabies","volume":"153","author":"Buettcher","year":"2023","journal-title":"Swiss Med. Wkly."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3855\/jidc.15222","article-title":"Scabies: Update on treatment and efforts for prevention and control in highly endemic settings","volume":"16","author":"Widaty","year":"2022","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000529135","article-title":"Use of Complementary and Alternative Medicine in Children with Scabies","volume":"30","author":"Akca","year":"2023","journal-title":"Complement. Med. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pt.2012.09.006","article-title":"Scratching the itch: New tools to advance understanding of scabies","volume":"29","author":"Mounsey","year":"2013","journal-title":"Trends Parasitol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/ced\/llac092","article-title":"Oral ivermectin to treat scabies: A comparison of two different regimens","volume":"48","author":"Balestri","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/ced.14954","article-title":"Successful treatment of resistant scabies with oral ivermectin in an 8-week-old infant","volume":"47","author":"Wiggins","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/dkz524","article-title":"Safety of high-dose ivermectin: A systematic review and meta-analysis","volume":"75","author":"Navarro","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Jittamala, P., Monteiro, W., Smit, M.R., Pedrique, B., Specht, S., Chaccour, C.J., Dard, C., Del Giudice, P., Khieu, V., and Maruani, A. (2021). A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009144"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jaad.2019.01.004","article-title":"Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials","volume":"80","author":"Thadanipon","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"102585","DOI":"10.1016\/j.tmaid.2023.102585","article-title":"\u201cOne-shot\u201d combined therapy with oral ivermectin and local benzyl benzoate: Is the current best therapeutic option in the era of permethrin resistant scabies?","volume":"53","author":"Bassi","year":"2023","journal-title":"Travel. Med. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/bjd.17348","article-title":"Risk factors for treatment failure in scabies: A cohort study","volume":"180","author":"Aussy","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/bjd\/ljad501","article-title":"Comparison of topical permethrin 5% vs. benzyl benzoate 25% treatment in scabies: A double-blinded randomized controlled trial","volume":"190","author":"Meyersburg","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e15897","DOI":"10.1111\/dth.15897","article-title":"Comparison of sulfur ointment and permethrin treatments in scabies","volume":"35","author":"Ertugrul","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/bjd\/ljae016","article-title":"Scabies therapy update: Should 25% benzyl benzoate emulsion be reconsidered as a first-line agent in classical scabies?","volume":"190","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0976-500X.107668","article-title":"Efficacy and safety of Tinospora cordifolia lotion in Sarcoptes scabiei var hominis-infected pediatric patients: A single blind, randomized controlled trial","volume":"4","author":"Castillo","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3892\/etm.2015.2503","article-title":"Acaricidal activity of extracts from Ligularia virgaurea against the Sarcoptes scabiei mite in vitro","volume":"10","author":"Luo","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4269\/ajtmh.14-0515","article-title":"Therapeutic Potential of Tea Tree Oil for Scabies","volume":"94","author":"Thomas","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Li, M., Feng, S., Huang, S., Guillot, J., and Fang, F. (2023). In Vitro Efficacy of Terpenes from Essential Oils against Sarcoptes scabiei. Molecules, 28.","DOI":"10.3390\/molecules28083361"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Nardoni, S., and Mancianti, F. (2022). Essential Oils against Sarcoptes scabiei. Molecules, 27.","DOI":"10.3390\/molecules27249067"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaad.2021.07.074","article-title":"Spinosad at 0.9% in the treatment of scabies: Efficacy results from 2 multicenter, randomized, double-blind, vehicle-controlled studies","volume":"86","author":"Seiler","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Pasay, C., Arlian, L., Morgan, M., Gunning, R., Rossiter, L., Holt, D., Walton, S., Beckham, S., and McCarthy, J. (2009). The Effect of Insecticide Synergists on the Response of Scabies Mites to Pyrethroid Acaricides. PLoS Neglected Trop. Dis., 3.","DOI":"10.1371\/journal.pntd.0000354"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Pasay, C., Mounsey, K., Stevenson, G., Davis, R., Arlian, L., Morgan, M., Vyszenski-Moher, D., Andrews, K., and McCarthy, J. (2010). Acaricidal Activity of Eugenol Based Compounds against Scabies Mites. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012079"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1468-3083.2006.01623.x","article-title":"Efficacy and tolerability of a new synergized pyrethrins thermofobic foam in comparison with benzyl benzoate in the treatment of scabies in convicts: The ISAC study (Studio Della scabbia in ambiente carcerario)","volume":"20","author":"Biele","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_74","first-page":"69","article-title":"Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: A prospective, randomised, investigator-blinded, comparative trial vs. permethrin cream","volume":"13","author":"Amerio","year":"2003","journal-title":"Eur. J. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.2340\/00015555-3468","article-title":"The Management of Scabies in the 21st Century: Past, Advances and Potentials","volume":"100","author":"Bernigaud","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_76","unstructured":"(2024, July 24). Medicines Development for Global Health. Efficacy and Safety Study of Moxidectin in Adults with Scabies. Available online: https:\/\/www.centerwatch.com\/clinical-trials\/listings\/NCT05875441\/efficacy-and-safety-study-of-moxidectin-in-adults-with-scabies."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Rinaldi, F., Chirico, R., Trink, A., and Pinto, D. (2023). Resistance and Pseudo-resistance to permethrin: The importance of controlling scabies. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1297337"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3855\/jidc.17750","article-title":"Pseudoresistance to permethrin in scabies","volume":"17","author":"Veraldi","year":"2023","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_79","first-page":"554","article-title":"Application errors associated with topical treatment of scabies: An observational study","volume":"18","author":"Nemecek","year":"2020","journal-title":"JDDG J. der Dtsch. Dermatol. Ges."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/23744235.2016.1266383","article-title":"Where to look for the scabies mite","volume":"49","author":"Veraldi","year":"2016","journal-title":"Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Salavastru, C.M., Cretu, S., Dascalu, M., Sendrea, A.M., Suru, A., and Tiplica, G.S. (2024). Scabies treatment with benzyl benzoate in patients younger than 2 years: A single-centre experience. J. Eur. Acad. Dermatol. Venereol.","DOI":"10.1111\/jdv.20048"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1525-1470.2002.00205.x","article-title":"Sulfur for Scabies Outbreaks in Orphanages","volume":"19","author":"Pruksachatkunakorn","year":"2002","journal-title":"Pediatr. Dermatol."},{"key":"ref_83","first-page":"e19","article-title":"Sulfur 17% ointment for topical treatment of scabies in children: Old but gold","volume":"63","author":"Baffa","year":"2023","journal-title":"Int. J. Dermatol."},{"key":"ref_84","first-page":"101144","article-title":"Ivermectin therapy for young children with scabies infection: A multicentre phase 2 non-randomized trial","volume":"49","author":"Gwee","year":"2024","journal-title":"Lancet Reg. Health\u2013West. Pac."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass Drug Administration for Scabies Control in a Population with Endemic Disease","volume":"373","author":"Romani","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Weill, A., Bernigaud, C., Mokni, M., Gil, S., Elefant, E., and Chosidow, O. (2021). Scabies-infested pregnant women: A critical therapeutic challenge. PLoS Neglected Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0008929"},{"key":"ref_87","unstructured":"Hayes, W.J., and Laws, E.R. (1990). Handbook of Pesticide Toxicology, Volume 3: Classes of Pesticides, Academic Press."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1471-0528.2007.01290.x","article-title":"Safety of benzyl benzoate lotion and permethrin in pregnancy: A retrospective matched cohort study","volume":"114","author":"Mytton","year":"2007","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1470-2045(15)70134-8","article-title":"Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate","volume":"16","author":"Guyton","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/bjd.13780","article-title":"Treatment of crusted scabies with acitretin","volume":"173","author":"Veraldi","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jinf.2004.08.033","article-title":"Crusted scabies: Clinical and immunological findings in seventy-eight patients and a review of the literature","volume":"50","author":"Roberts","year":"2005","journal-title":"J. Infect."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e702","DOI":"10.1097\/MJT.0000000000001163","article-title":"Can Acitretin Be Effective Alone in the Treatment of Crusted Scabies?","volume":"28","author":"Metin","year":"2020","journal-title":"Am. J. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-024-08298-8","article-title":"Scabies vaccines: Where we stand and challenges ahead","volume":"123","author":"Sharaf","year":"2024","journal-title":"Parasitol. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1016\/j.jid.2016.08.021","article-title":"Research Techniques Made Simple: Assessing Risk of Bias in Systematic Reviews","volume":"136","author":"Drucker","year":"2016","journal-title":"J. Investig. Dermatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/18\/5511\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:58:27Z","timestamp":1760111907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/18\/5511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":94,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["jcm13185511"],"URL":"https:\/\/doi.org\/10.3390\/jcm13185511","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]}}}